Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
06/11/2019 06/12/2019 06/13/2019 06/14/2019 06/17/2019 Date
76.1(c) 76.57(c) 75.98(c) 75.98(c) 75.47 Last
3 012 467 2 658 874 1 963 865 2 498 012 1 989 179 Volume
-1.55% +0.62% -0.77% 0.00% -0.67% Change
More quotes
Financials (EUR)
Sales 2019 36 127 M
EBIT 2019 9 112 M
Net income 2019 4 955 M
Debt 2019 14 481 M
Yield 2019 3,98%
Sales 2020 37 608 M
EBIT 2020 9 756 M
Net income 2020 5 900 M
Debt 2020 11 966 M
Yield 2020 4,14%
P/E ratio 2019 18,54
P/E ratio 2020 16,18
EV / Sales2019 3,11x
EV / Sales2020 2,92x
Capitalization 97 908 M
More Financials
Company
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (85.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies,... 
Sector
Pharmaceuticals
Calendar
06/17Presentation
More about the company
Surperformance© ratings of Sanofi
Trading Rating : Investor Rating :
More Ratings
Latest news on SANOFI
01:03pVoyager Therapeutics Up 9%; Restructures Relationship with Sanofi Genzyme
DJ
08:35aVoyager Therapeutics Restructures Gene Therapy Relationship with Sanofi Genzy..
DJ
06/12SANOFI : announces positive data from Soliquas diabetes trial
AQ
06/11SANOFI : talks up personalized diabetes care in patient-centric awareness push
AQ
06/09SANOFI : Soliqua® Phase 3 results significantly lowered blood sugar levels compa..
AQ
06/07SANOFI : on Track for Largest Percent Increase Since October 2011 -- Data Talk
DJ
06/07France's Sanofi bets on new CEO to drive sluggish drug sales
RE
06/07Drugmaker Sanofi hires Hudson from Novartis as CEO
RE
06/07EUROPE MARKETS: Europe Stocks Rise As Investors Digest ECB Announcement
DJ
06/07Drugmaker Sanofi hires Hudson from Novartis as CEO
RE
More news
Analyst Recommendations on SANOFI
More recommendations
Stock Trading Strategies
SANOFI - 05/16
Helped by a technical support level
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
12:52pARRAY BIOPHARMA : Pfizer makes $10.6 billion cancer bet in cash deal for Array B..
RE
10:35aASTRAZENECA : GSK pharma head flags need for speed in high-pressure drug market
RE
09:53aPFIZER : to Buy Array BioPharma in $10.64 Billion Deal -- 3rd Update
DJ
09:45aGLOBAL MARKETS LIVE : Nissan, Huawei, Deutsche Bank, Pfizer…
08:54aPFIZER : to Buy Array BioPharma in $10.64 Billion Deal -- 2nd Update
DJ
More sector news : Pharmaceuticals - NEC
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 83,5 €
Spread / Average Target 6,7%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI0.42%103 743
JOHNSON & JOHNSON8.55%348 981
PFIZER-2.04%233 072
ROCHE HOLDING LTD.13.39%227 848
NOVARTIS20.35%220 893
MERCK AND COMPANY8.34%206 641